Delta-Fly Pharma (TSE:4598) Total Stockholders Equity : 円1,689.15 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Delta-Fly Pharma Total Stockholders Equity?

Delta-Fly Pharma's Total Stockholders Equity for the quarter that ended in Dec. 2023 was 円1,689.15 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Delta-Fly Pharma's Book Value per Share for the quarter that ended in Dec. 2023 was 円205.25. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Delta-Fly Pharma's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.00.

Delta-Fly Pharma Total Stockholders Equity Historical Data

The historical data trend for Delta-Fly Pharma's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Delta-Fly Pharma Total Stockholders Equity Chart

Delta-Fly Pharma Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Stockholders Equity

Get a 7-Day Free Trial

3,504.11

2,056.19

2,078.73

1,233.16

791.20

Delta-Fly Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															750.73	791.20	722.46	402.84	1,689.15

Delta-Fly Pharma (TSE:4598) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Delta-Fly Pharma's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1689.151	-	0)	/	8.2297
	=	205.25

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Delta-Fly Pharma's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	1689.151
	=	0.00

Delta-Fly Pharma Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Delta-Fly Pharma's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Delta-Fly Pharma (TSE:4598) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Delta-Fly Pharma Inc (TSE:4598) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Miyajima Kinno 37-5, Tokushima Prefecture, Kawauchi Town, Tokushima, JPN, 771-0116

Website

http://www.delta-flypharma.co.jp

Delta-Fly Pharma Inc is a Japan-based company mainly engaged in the discovery and development of gentle anti-cancer agents with module technology.

Delta-Fly Pharma (TSE:4598) Headlines

No Headlines